ZYMERON CORPORATION

DURHAM, NC · UEI GAMMMRQ6QMN1 · CAGE 7MVB7

Minority-ownedSmall businessSmall-business set-aside

SAM.gov registration active · expires June 8, 2027(as of the monthly SAM public extract)

Awarded (5-yr transactions)

Set-aside awards seen

Latest period end

Jul 2027

Largest contract awards

HT942523C0067$3.0M
DHA SBIR DIRECT TO PH II MEDICAL R&D CONTRACT AWARDED FROM PROPOSAL NO.-H2D-0119 FOR "DEVELOPMENT FOR SHOCKDEFENDER AGAINST HEMORRHAGIC SHOCK"
Defense Health Agency · NAICS 541715 · Sep 2023 – Jan 2026 · official record ↗
W81XWH22C0012$3.0M
AWARD OF ZYMERON'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "DEVELOPMENT FOR A NOVEL COUNTERMEASURE, RADIODEFENDER, AS A RADIOPROTECTOR FOR HEMATOPOIETIC ACUTE RADIATION SYNDROME"
Defense Health Agency · NAICS 541715 · Feb 2022 – Jun 2026 · official record ↗
HT942524C0057$3.0M
DHA SBIR DIRECT PHASE II H2D-0243 RAPID SAMPLE PROCESSING DEVICE TO SUPPORT BATTLEFIELD WOUND INFECTION DIAGNOSTICS
Defense Health Agency · NAICS 541715 · Sep 2024 – Jul 2027 · official record ↗
75N93019C00031$1.5M
COMPLETE SBIR TOPIC 46 PHASE II TASKS
National Institutes of Health · NAICS 541714 · Aug 2019 – Jul 2023 · official record ↗
75N93021C00035$1.3M
RAPID POINT OF CARE TESTS TO SIMULTANEOUSLY QUANTIFY ANTI-TB DRUGS IN BLOOD.
National Institutes of Health · NAICS 541714 · Aug 2021 – Mar 2024 · official record ↗
W81XWH22C0073$1.1M
AWARD OF ZYMERON'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "NOVEL ANTIBIOTICS TARGETING MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA INFECTIONS"
Department of the Army · NAICS 541715 · Jul 2022 – Nov 2024 · official record ↗
W81XWH21C0008$1.1M
MEDICAL RESEARCH AND DEVELOPMENT ARMY STTR PH II PROPOSAL NO. A2-8349 TITLED LONG LASTING DRUG IMPLANTS FOR MALARIA CHEMOPROPHYLAXIS.
Department of the Army · NAICS 541715 · Feb 2021 – Jun 2023 · official record ↗
HR001122C0128$990K
AUTOMATED PARTIAL OCCLUSION FOR TRUNCAL HEMORRHAGE CONTROL SBIR PHASE II AWARD
Defense Advanced Research Projects Agency · NAICS 541714 · Aug 2022 – Aug 2024 · official record ↗
HDTRA118C0043$983K
DERMAL MEDICAL COUNTERMEASURES FOR CHEMICAL WEAPONS EXPOSURE
Defense Threat Reduction Agency · NAICS 541715 · Sep 2018 – Sep 2021 · official record ↗
75N93018C00015$599K
THE PURPOSE OF THIS CONTRACT IS TO DEVELOP IMPRINTED POLYMER RESINS FOR THE PURIFICATION OF HIV ENVELOPE VACCINE CANDIDATES
National Institutes of Health · NAICS 541714 · Jul 2018 – Jul 2021 · official record ↗
75N91022C00029$400K
SBIR TOPIC 441. ZYMERON WILL DEVELOP USER-FRIENDLY TECHNOLOGIES AND DEVICES TO CREATE AN AT-HOME HEPATITIS C VIRUS TEST.
National Institutes of Health · NAICS 541714 · Sep 2022 – Sep 2023 · official record ↗
75N93022C00019$300K
POINT-OF-CARE (POC) DIAGNOSTICS FOR ANTIMICROBIAL RESISTANT (AMR) ENTERIC BACTERIAL AND PARASITIC PATHOGENS
National Institutes of Health · NAICS 541715 · Jul 2022 – Jun 2023 · official record ↗

Is this your company?

Claim it free on GovScout: matched SAM.gov opportunities for your NAICS codes, incumbent intel on every recompete, and monitoring so your SAM registration never lapses.

Claim your profile — free

Public records from FPDS (via USAspending.gov) and SAM.gov. Figures reflect harvested award data and may not be complete; verify against the linked official records. Not an endorsement. Company in the data by mistake or wish to update it? Email support@usegovscout.com.